Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

JAMA. 2021 Feb 23;325(8):780-781. doi: 10.1001/jama.2021.0600.

Authors

Tom Shimabukuro¹, Narayan Nair²

Affiliations

¹ Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
² Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland.

No abstract available

MeSH terms

Adult
Anaphylaxis / epidemiology
Anaphylaxis / etiology*
COVID-19 Vaccines / adverse effects*
Female
Humans
Hypersensitivity / epidemiology
Hypersensitivity / etiology*
Male
Middle Aged
United States / epidemiology

Substances

COVID-19 Vaccines

Grants and funding

CC999999/ImCDC/Intramural CDC HHS/United States